Syneron Medical Ltd. ELOS
No live quote for ELOS yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 11.00
Ratings (-2m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.09 | 0.0% | 79.09M | +5.5% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.08 | 0.0% | 76.20M | +6.5% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 311.61M | +4.5% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 330.30M | +6.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 11, 2017 | Maxim Group | Downgrade | — | Hold |
| Aug 4, 2016 | Leerink Swann | Downgrade | — | Market Perform |
| Mar 2, 2015 | Brean Capital | Initiated | — | Buy |